Portable Neuromodulation Stimulator Registry for People With Multiple Sclerosis

计划入组 150 人 · 首次发布于 2025 年 4 月 16 日

PoNS® Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Single-Arm Study

计划入组 30 人 · 首次发布于 2024 年 3 月 29 日

Portable Neuromodulation Stimulator (PoNS®) Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Randomized Controlled Trial.

计划入组 60 人 · 首次发布于 2024 年 6 月 24 日

PDE4 stimulator

Wnt Pathway Stimulator (Almirall)

ABC-transporter protein stimulator

ANM Adaptive Neuromodulation GmbH

Germany

LivaNova

United Kingdom

EMvision Medical Devices Ltd

United Healthcare Approves Reimbursement for Helius Medical's PoNS Device for MS Patients

Helius Medical's PoNS Device Exceeds Enrollment Target in Stroke Pivotal Study, Eyes 2025 FDA Submission

Portable tACS Shows Promise for Treatment-Resistant Depression in Multicenter Randomized Trial